Logo

American Heart Association

  116
  0


Final ID:

How do we SELECT incretin analogues and SUSTAIN their impact? Clinical approaches for short and long-term obesity care

  • Jastreboff, Ania  ( Yale School of Medicine , New Haven , Connecticut , United States )
  • Lingvay, Ildiko  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Author Disclosures:
    Ania Jastreboff: DO have relevant financial relationships ; Researcher:Eli Lilly:Active (exists now) ; Advisor:Regeneron:Active (exists now) ; Individual Stocks/Stock Options:Intellihealth:Active (exists now) ; Advisor:Scholar Rock:Active (exists now) ; Advisor:Structure Therapeutics:Active (exists now) ; Advisor:Zealand:Active (exists now) ; Advisor:Weight Watchers:Active (exists now) ; Advisor:Pfizer, Terns Pharmaceuticals:Active (exists now) ; Advisor:Novo Nordisk:Active (exists now) ; Advisor:Eli Lilly:Active (exists now) ; Advisor:Boehringer Ingelheim, Biohaven:Active (exists now) ; Advisor:Amgen, AstraZeneca:Active (exists now) ; Researcher:Rhythm Pharmaceuticals:Active (exists now) ; Researcher:Boehringer Ingelheim:Active (exists now) ; Researcher:Novo Nordisk:Active (exists now) | Ildiko Lingvay: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:
More abstracts on this topic:
Panel Discussion

Nauck Michael, Drucker Daniel, Pratley Richard

Patient Interview

Ndumele Chiadi, Taub Pam

More abstracts from these authors:
Optimizing the medical approach to your patient with obesity

Jastreboff Ania, Stanford Fatima, Lingvay Ildiko, Kahan Scott, Gudzune Kimberly

Debate 1: Early incretin therapy for long term brain health: Get started already! - No, the data is not there yet

Jastreboff Ania, Lingvay Ildiko, Marso Steven, Goldenberg Ronald

You have to be authorized to contact abstract author. Please, Login
Not Available